Research Background
Accurately assessing the pathogenicity of newly discovered variants, especially those at splice sites, is crucial for definitive diagnosis in rare genetic disorders. A study focusing on a family with Glass syndrome (SATB2-associated syndrome) clearly demonstrates the key role of the RDDC RNA Splicer tool in this process. In this research, RDDC provided precise functional predictions for a novel splice site variant, c.1543-1G>A, in the SATB2 gene, offering strong in silico evidence for its pathogenicity and ultimately aiding in the family's genetic diagnosis and counseling.
Research Challenge: WES Identifies a Splice Site VUS
The challenge in this study stemmed from a family where the proband (a 13-year-old boy) and his mother both exhibited typical features of Glass syndrome, including severe intellectual disability, distinct facial characteristics, and digital anomalies. To identify the genetic cause, the research team performed trio-Whole Exome Sequencing (WES). This revealed a novel heterozygous variant at the canonical splice acceptor site of the SATB2 gene: c.1543-1G>A, present in both the proband and his mother but absent in the father. This variant was not reported in public databases, classifying it as a "Variant of Uncertain Significance" (VUS) whose specific impact on gene function required further clarification.
RDDC's Precise Prediction: Unveiling Potential Pathogenic Mechanisms
To evaluate the potential pathogenic mechanism of this VUS, the team utilized the RDDC RNA Splicer tool. Based on AI models, the RDDC tool accurately predicts the effects of variants on mRNA splicing. For the c.1543-1G>A variant, RDDC predicted two primary aberrant splicing consequences:
Introduction of a new splice acceptor site
This would lead to a frameshift and premature termination codon, resulting in a truncated, non-functional protein.
Skipping of exon 10
This involves the entire exon 10 being omitted during mRNA maturation, also leading to an abnormal protein structure.
Both predictions clearly pointed towards a loss-of-function effect for this variant, disrupting the normal structure of the SATB2 protein (specifically impacting the DNA-binding function of its CUT2 domain) and thus causing Glass syndrome.
Case Value: RDDC Assists in Assessing VUS Pathogenicity
This clear prediction of the pathogenic mechanism provided by the RDDC tool, combined with the variant's co-segregation within the family (present in affected mother and son, absent in unaffected father) and its location within a critical functional domain, collectively formed a strong chain of evidence for the pathogenicity of c.1543-1G>A. This case highlights the value of the RDDC RNA Splicer in functionally interpreting splice site VUS. It enables rapid and reliable functional prediction for novel, rare variants identified via WES, effectively assisting clinicians in pathogenicity assessment. This provides crucial molecular evidence for the precise diagnosis of rare diseases like Glass syndrome, as well as for genetic counseling and prenatal diagnosis (e.g., amniocentesis gene testing).
Content Source and Disclaimer
This article is a compilation and interpretation of the scientific study cited below, intended to highlight the application of RDDC bioinformatics tools. All research data and conclusions belong to the original authors and publication.
Original Article
Guo M¹, Guo R², Gao J², Cao G², Zhao C¹, Yue H¹, Ye T², Xue H¹. Genetic analysis of a pathogenic gene in a family with GLASS syndrome. (Note: Full publication details are missing)
Affiliation: ¹Department of Pediatrics, Shanxi Medical University; ²Affiliated Hospital information pending.
Year: 2025 (Note: Inferred from text)
